Monoclonal Antibodies Make Headway in Sjögren Treatment

Positive results were reported from the DAHLIAS study of nipocalimab, the TWINSS study of iscalimab, and a phase 1 trial of tibulizumab, but it was negative news for lusvertikimab.
Medscape Medical News

source https://www.medscape.com/viewarticle/monoclonal-antibodies-make-promising-headway-sj%C3%B6gren-2024a1000ec3?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

A case report of pudendal arteries angioplasty with sirolimus drug-coated balloon and drug-eluting stent associated with intracavernous autologous peripheral blood mononuclear cells injection for untreatable vasculogenic erectile dysfunction.